Veracyte VCYT Stock
Veracyte Price Chart
Veracyte VCYT Financial and Trading Overview
| Veracyte stock price | 24.33 USD |
| Previous Close | 24.63 USD |
| Open | 24.6 USD |
| Bid | 33.3 USD x 200 |
| Ask | 59.52 USD x 200 |
| Day's Range | 23.47 - 24.65 USD |
| 52 Week Range | 21.91 - 60.91 USD |
| Volume | 2.03M USD |
| Avg. Volume | 1.79M USD |
| Market Cap | 1.96B USD |
| Beta (5Y Monthly) | 1.96 |
| PE Ratio (TTM) | 16.006578 |
| EPS (TTM) | 1.54 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 44.6 USD |
VCYT Valuation Measures
| Enterprise Value | 1.63B USD |
| Trailing P/E | 16.006578 |
| Forward P/E | 15.531736 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.3746676 |
| Price/Book (mrq) | 1.3691615 |
| Enterprise Value/Revenue | 2.808 |
| Enterprise Value/EBITDA | 14.994 |
Trading Information
Veracyte Stock Price History
| Beta (5Y Monthly) | 1.96 |
| 52-Week Change | -37.40% |
| S&P500 52-Week Change | 12.28% |
| 52 Week High | 60.91 USD |
| 52 Week Low | 21.91 USD |
| 50-Day Moving Average | 42.57 USD |
| 200-Day Moving Average | 42.46 USD |
VCYT Share Statistics
| Avg. Volume (3 month) | 1.79M USD |
| Avg. Daily Volume (10-Days) | 4.21M USD |
| Shares Outstanding | 80.7M |
| Float | 80.19M |
| Short Ratio | 8.08 |
| % Held by Insiders | 0.53% |
| % Held by Institutions | 119.13% |
| Shares Short | 9.56M |
| Short % of Float | 13.99% |
| Short % of Shares Outstanding | 11.84% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 21.80% |
| Operating Margin (ttm) | 15.02% |
| Gross Margin | 74.15% |
| EBITDA Margin | 18.72% |
Management Effectiveness
| Return on Assets (ttm) | 3.71% |
| Return on Equity (ttm) | 9.42% |
Income Statement
| Revenue (ttm) | 581.78M USD |
| Revenue Per Share (ttm) | 7.29 USD |
| Quarterly Revenue Growth (yoy) | 15.09% |
| Gross Profit (ttm) | 431.44M USD |
| EBITDA | 108.94M USD |
| Net Income Avi to Common (ttm) | 126.85M USD |
| Diluted EPS (ttm) | 1.52 |
| Quarterly Earnings Growth (yoy) | 64.60% |
Balance Sheet
| Total Cash (mrq) | 370.53M USD |
| Total Cash Per Share (mrq) | 4.59 USD |
| Total Debt (mrq) | 40.74M USD |
| Total Debt/Equity (mrq) | 2.84 USD |
| Current Ratio (mrq) | 5.556 |
| Book Value Per Share (mrq) | 17.77 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 173.88M USD |
| Levered Free Cash Flow (ttm) | 110.92M USD |
Profile of Veracyte
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 6000 Shoreline Court |
| ZIP | 94080 |
| Phone | 650 243 6300 |
| Website | https://www.veracyte.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 755 |
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Q&A For Veracyte Stock
What is a current VCYT stock price?
Veracyte VCYT stock price today per share is 24.33 USD.
How to purchase Veracyte stock?
You can buy VCYT shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Veracyte?
The stock symbol or ticker of Veracyte is VCYT.
Which industry does the Veracyte company belong to?
The Veracyte industry is Diagnostics & Research.
How many shares does Veracyte have in circulation?
The max supply of Veracyte shares is 80.7M.
What is Veracyte Price to Earnings Ratio (PE Ratio)?
Veracyte PE Ratio is 15.79870100 now.
What was Veracyte earnings per share over the trailing 12 months (TTM)?
Veracyte EPS is 1.54 USD over the trailing 12 months.
Which sector does the Veracyte company belong to?
The Veracyte sector is Healthcare.
Veracyte VCYT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
25136.27 USD — |
-0.91
|
7.74B USD — | 24872.41 USD — | 25423.09 USD — | — - | 7.74B USD — |
|
US Tech US 700 Small Cap Value N
NQUS700SCVN
US
|
3111.6 USD — |
+0.33
|
— — | 3090.53 USD — | 3117.52 USD — | — - | — — |
|
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3020.37 USD — |
-0.22
|
— — | 2991.33 USD — | 3035.56 USD — | — - | — — |
|
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
3748.08 USD — |
-0.7
|
— — | 3701.51 USD — | 3782.39 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7211.27 USD — |
-0.5
|
— — | 7149.19 USD — | 7238.9 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1368.29 USD — |
-0.34
|
— — | 1358.68 USD — | 1373.65 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31061.46 USD — |
-0.9
|
— — | 30735.41 USD — | 31415.87 USD — | — - | — — |
|
US Tech US 700 Small Cap Value I
NQUS700SCV
US
|
2704.72 USD — |
+0.32
|
— — | 2686.41 USD — | 2709.87 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
1937.83 USD — |
-1.05
|
— — | 1915.46 USD — | 1955.74 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
